# Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

> **NCT07078929** · PHASE1 · RECRUITING · sponsor: **Chulalongkorn University** · enrollment: 16 (estimated)

## Conditions studied

- Relapse B Acute Lymphoblastic Leukemia
- Refactory Childhood Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** CD19-IL7Ra CAR-T cells

## Key facts

- **NCT ID:** NCT07078929
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07078929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07078929, "Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07078929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*